Fas (CD95/Apo-1)–Mediated Damage to Ventricular Myocytes Induced by Cytotoxic T Lymphocytes From Perforin-Deficient Mice
- 9 March 1998
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 82 (4), 438-450
- https://doi.org/10.1161/01.res.82.4.438
Abstract
—Cytotoxic T lymphocytes (CTLs) that infiltrate the heart are important immune effectors implicated in heart transplant rejection, myocarditis, and other cardiomyopathies. To investigate the mechanism(s) underlying CTL damage to the myocardium through activation of the Fas receptor (Fas/CD95/Apo-1) by the Fas ligand, we explored the interaction between peritoneal exudate CTLs (PELs), derived from perforin gene–knockout (P−/−) mice, and murine ventricular myocytes. Fas expression on isolated ventricular myocytes was demonstrated immunohistochemically. Action potentials, [Ca2+]i transients, and contractions of myocytes conjugated to P−/− PELs or treated with the apoptosis-inducing anti-Fas monoclonal antibody Jo2 were recorded. Action potential characteristics of nonconjugated myocytes and myocytes conjugated with P−/− PELs were, respectively, as follows: Vm, −73.2±1.5 and −53.6±6.4 mV (mean±SEM); action potential amplitude, 117.9±3.9 and 74.3±21.2 mV; and action potential duration at 80% repolarization, 17±6 and 42±13 milliseconds (all P<.05). P−/− PELs also induced early and delayed afterdepolarizations as well as arrhythmogenic activity. Diastolic [Ca2+]i increased during the cytocidal interaction with P−/− PELs, from a fluorescence ratio of 0.82±0.05 (n=7) to 1.98±0.09 (n=13) (P<.05). All of the effects caused by P−/− PELs were reproduced by incubating the myocytes with Jo2. Heparin (50 μg/mL), an antagonist of inositol trisphosphate (IP3)–operated sarcoplasmic reticulum Ca2+ channels, or U-73122 (2 μmol/L), a phospholipase C inhibitor, but not the inactive agonist U-73343, prevented Fas-mediated myocyte dysfunction. Additionally, intracellular application (through the patch pipette) of the active IP3 analogue, inositol 1,4,5-trisphosphate, but not the inactive analogue, inositol 1,3,4-trisphosphate, caused electrophysiological changes resembling those resulting from P−/− PELs and Jo2, suggesting that CTL-induced Fas-based myocyte dysfunction is mediated by IP3. We conclude that a Fas-based perforin-independent mechanism of CTL action can account for the immunopathology seen in the allotransplanted heart, myocarditis, and dilated cardiomyopathy.Keywords
This publication has 35 references indexed in Scilit:
- Immune effector mechanisms in heart transplant rejectionCardiovascular Research, 1994
- Anti-αβ T cell receptor antibody prevents the progression of experimental autoimmune myocarditisClinical and Experimental Immunology, 1994
- Demonstration of a Specific [3H]INS(1,4,5)P3 Binding Site in Rat Heart Sarcoplasmic ReticulumJournal of Molecular and Cellular Cardiology, 1994
- INOSITOL-1,4,5-TRISPHOSPHATE [INS(1,4,5)P3] AND INS(1,4,5)P3RECEPTOR CONCENTRATIONS IN HEART TISSUESClinical and Experimental Pharmacology and Physiology, 1994
- Inositol 1,4,5-trisphosphate receptor expression in cardiac myocytes.The Journal of cell biology, 1993
- Effects of phospholipase C on action potentials and intracellular Ca2+ concentration in guinea pig heart.Japanese Circulation Journal, 1993
- Potential arrhythmogenic role of cyclic adenosine monophosphate (AMP) and cytosolic calcium overload: Implications for prophylactic effects of beta-blockers in myocardial infarction and proarrhythmic effects of phosphodiesterase inhibitorsJournal of the American College of Cardiology, 1992
- Influence of heparins on inositol 1,4,5-trisphosphate-induced calcium mobilization in permeabilized human plateletsBiochemical Medicine and Metabolic Biology, 1991
- 2,3,7,8-Tetrachlorodibenzo- p -Dioxin Kills Immature Thymocytes by Ca 2+ -Mediated Endonuclease ActivationScience, 1988
- REJECTION OF ASCITES TUMOR ALLOGRAFTSThe Journal of Experimental Medicine, 1972